Autonomic denervation with magnetic nanoparticles

Circulation

Volumn 122, Issue 25, 2010, Pages 2653-2659

  Yu, Lilei ^a,b   Scherlag, Benjamin J ^b   Dormer, Kenneth ^c   Nguyen, Kytai T ^e   Pope, Carey ^f   Fung, Kar Ming ^d   Po, Sunny S ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Heart Rhythm Institute   (United States)

^c Department of Physiology ^*  (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e The University of Texas at Arlington   (United States)

^f OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

arrhythmia; atrial fibrillation; magnetic nanoparticles; nervous system, autonomic

Indexed keywords

MAGNETIC NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DENERVATION; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART STIMULATION; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM;

ACRYLAMIDES; ANIMALS; ATRIAL FIBRILLATION; AUTONOMIC DENERVATION; CATHETER ABLATION; DOGS; FERRIC COMPOUNDS; GANGLIA, AUTONOMIC; HEART ATRIA; MAGNETICS; METAL NANOPARTICLES; MODELS, ANIMAL; NEUROTOXINS;

EID: 78650680731     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.940288     Document Type: Article

References (45)

1. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753-2759.
2. Amar D, Zhang H, Miodownik S, Kadish A. Competing autonomic mechanisms precedes the onset of postoperative atrial fibrillation. J Am Coll Cardiol. 2003;42:1262-1268.
3. Ogawa M, Zhou S, Tan AY, Song J, Gholmieh G, Fishbein MC, Lou H, Siegel RJ, Karagueuzian HS, Chen LS, Lin SF, Chen PS. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J Am Coll Cardiol. 2007;50:335-343.
4. Patterson E, Po SS, Scherlag B, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2:624-631.
5. Randall WC, Armour JA, Geis WP, Lippincott DB. Regional cardiac distribution of the sympathetic nerves. Fed Proc. 1972;31:1199-1208.
6. Ardell JL. Structure and function of the mammalian intrinsic cardiac neurons. In: Armour JA, Ardell JL, eds. Neurocardiology. New York, NY: Oxford University Press; 1994; chap. 5.
7. Pauza DH, Skripka V, Pauziene N. Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histo-chemical staining with acetylcholinesterase. Cells Tissues Organs. 2002; 172:297-320.
8. Scherlag BJ, Yamanashi WS, Patel U, Lazzara R, Jackman WM. Auto-nomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol. 2005;45:1878-1886.
9. Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, Wu R, Geng N, Lazzara R, Jackman WM. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006;3:201-208.
10. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, Ghias M, Jackman WM, Lazzara R, Jiang H, Po SS. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1: 184-192.
11. Lin J, Scherlag BJ, Zhou J, Lu Z, Patterson E, Jackman WM, Lazzara R, Po SS. Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol. 2007;18:1197-1205.
12. Po SS, Nakagawa H, Jackman WM. Localization of left atrial gangli-onated plexi in patients with atrial fibrillation. J Cardiovasc Electro-physiol. 2009;20:1186-1189.
13. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi SW, Patterson E, Po S, Lazzara R. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005; 13:37-42.
14. Danik S, Neuzil P, Avila A, Malchano ZJ, Kralovec S, Ruskin JN, Reddy VY. Evaluation of catheter ablation of periatrial ganglionic plexi in patients with atrial fibrillation. Am J Cardiol. 2008;102:578-583.
15. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, Katritsis DG. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6:1257-1264.
16. Pokushalov E, Turov A, Shugayev P, Artyomenko S, Romanov A, Shi-rokova N. Catheter ablation of left atrial ganglionated plexi for atrial fibrillation. Asian Cardiovasc Thorac Ann. 2008;16:194-201.
17. Pokushalov E. The role of autonomic denervation during catheter ablation of atrial fibrillation. Curr Opin Cardiol. 2008;23:55-59.
18. Neuberger T, Schöpf B, Hofmann H, Hofmann M, Rechenberg BV. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater. 2005;293:483-496.
19. Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006; 58:1471-1504.
20. Ito A, Shinkai M, Honda H, Kobayshi T. Medical application of func-tionalized magnetic nanoparticles. J Biosci Bioeng. 2005;100:1-11.
21. Kim J, Lee JE, Lee SH, Yu JH, Lee JH, Park TG, Hyeon T. Designed fabrication of a multifunctional polymer nanomedical platform from simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater. 2008;20:478-483.
22. Dormer K, Seeney C, Lewelling K, Lian G, Gibson D, Johnson M. Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field. Biomaterials. 2005;26:2061-2072.
23. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nano-particles for biomedical applications. Biomaterials. 2005;26:3995-4021.
24. Rahimi M, Youself M, Cheng Y, Meletis EI, Eberhart RC, Nguyen KT. Formulation and characterization of covalently coated magnetic nanogel. J Nanosci Nanotechnol. 2009;9:4128-4134.
25. Rahimi M, Kilaru S, El Hajj Sleiman G, Saleh A, Rudkevich D, Nguyen KT. Synthesis and characterization of thermo-sensitive nanoparticles for drug delivery applications. J Biomed Nanotechnol. 2008;4:482-490.
26. Salehi R, Arsalani N, Davaran S, Entezami AA. Synthesis and characterization of thermosensitive and pH-sensitive pol (N-isopropylacrylam- ide-acrylamide-vinylpyrrolidone) for use in controlled release of nal-trexone. J Biomed Mater Res A. 2009;89:919-928.
27. Wakamatsu H, Yamamoto K, Nakao A, Aoyagi T. Preparation and characterization of temperature-responsive nanoparticles conjugated with N-isopropylacrilamide-based functional copolymer. J Magn Magn Mater. 2006;302:327-333.
28. Wadajkar A, Koppolu B, Rahimi M, Nguyen KT. Cytotoxic evaluation of N-isopropylacrylamide monomers and temperature-sensitive poly(N- isopropylacrylamide) nanoparticles. J Nanopart Res. 2009;11: 1375-1382.
29. Chastek T, Wadajkar A, Nguyen KT, Hudson SD, Chastek T. Polyglycol-templated synthesis of poly(N-isopropyl acrylamide) microgels with improved biocompatibility. Colloid Polym Sci. 2010;288:105-114.
30. Zhou J, Scherlag BJ, Edwards J, Jackman WM, Lazzara R, Po SS. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol. 2007; 18:83-90.
31. Hou Y, Scherlag BJ, Lin J, Lu Z, Truong K, Patterson E, Lazzara R, Jackman W, Po SS. Ganglionated plexi modulating extrinsic cardiac autonomic nervous inputs: effects on sinus rate, AV conduction, refractoriness and AF inducibility. J Am Coll Cardiol. 2007;50:61-68.
32. Hou Y, Scherlag BJ, Zhou J, Song J, Patterson E, Lazzara R, Jackman WM, Po SS. Interactive atrial neural network: determining the connections between ganglionated plexi. Heart Rhythm. 2007;4:56-63.
33. Asmatulu R, Zalich MA, Claus RO, Riffle JS. Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater. 2005;292:108-109.
34. Pelton R. Temperature-sensitive aqueous microgels. Adv Colloid Interface Sci. 2000;85:1-33.
35. Niu G, Scherlag BJ, Lu Z, Ghias M, Zhang Y, Patterson E, Dasari TW, Zacharias S, Lazzara R, Jackman WM, Po SS. An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2009;2:384-392.
36. Brashear A. The safety and tolerability of botulinum toxin for the treatment of cervical dystonia. Expert Opin Drug Saf. 2005;4:241-249.
37. Brin MF. Development of future indications for BOTOX. Toxicon. 2009; 54:668-674.
38. Tanil H, Hashimoto K. Effect of acrylamide and related compounds on glycolytic enzymes of rat brain. Toxicol Lett. 1985;26:79-84. (Pubitemid 15233267)
39. Howland RD. The etiology of acrylamide neuropathy: enolase, phospho-fructokinase and glyceraldehyde-3-phosphotase dehydrogenase activities in peripheral nerve, spinal cord, brain and skeletal muscle of acrylam-ide-intoxicated cats. Toxicol Appl Pharmacol. 1981;60:324-333.
40. LoPachin RM. Acrylamide neurotoxicity: neurological, morphological and molecular endpoints in animal models. Adv Exp Med Biol. 2005;561: 21-37.
41. LoPachin RM, Ross JF, Reid ML, Das S, Mansukhani S, Lehning EJ. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. Neurotoxicology. 2002;23:95-110.
42. Lopachin RM, Gavin T. Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms. J Agric Food Chem. 2008;56:5994-6003.
43. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
44. Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD. Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13:1272-1279.
45. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006;3:701-708.